Three Days Into Trial, Cordis Hacks At Boston's Claims
In another bid for damage control in the stent suit Boston Scientific Corp. filed against it five years ago, Johnson & Johnson subsidiary Cordis Corp. has asked for judgment as a...To view the full article, register now.
Already a subscriber? Click here to view full article